Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, CFO, Chief Accounting Officer
2025-04-09–present
Jon P. Stonehouse
Board Member
Biocryst Pharmaceuticals Inc (BCRX)Chief Accounting Officer
Biocryst Pharmaceuticals Inc (BCRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Biocryst Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get BCRX alertsAbout Jon P. Stonehouse
Jon P. Stonehouse is recorded as Board Member at Biocryst Pharmaceuticals Inc (BCRX) since June 11, 2026 and CFO and Chief Accounting Officer at Biocryst Pharmaceuticals Inc (BCRX) since April 9, 2025. Biocryst Pharmaceuticals Inc reported in an 8-K filed June 12, 2026 that Jon P. Stonehouse was appointed director, effective June 11, 2026. Biocryst Pharmaceuticals Inc reported in an 8-K filed April 10, 2025 that Jon P. Stonehouse was appointed Interim Chief Financial Officer and Interim Principal Accounting Officer, effective April 9, 2025. Biocryst Pharmaceuticals Inc reported in an 8-K filed April 10, 2025 that Jon P. Stonehouse was appointed Interim Principal Accounting Officer, effective April 9, 2025. Equibles holds 4 filed executive changes naming Jon P. Stonehouse; each is listed under recent activity with its source filing. The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $12,951,082 for Jon P. Stonehouse in fiscal 2025, including a base salary of $728,466. Disclosed compensation is on record for 9 fiscal years. Biocryst Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Biocryst Pharmaceuticals Inc includes Charles Gayer (CEO and Board Member), Charlie Gayer (CEO and Board Member), Vincent J. Milano (Chairman and Board Member) and 7 others.
“| Jon P. Stonehouse | 173,944,412 | 9,911,054 |”
“On April 7, 2025, the Board appointed Jon P. Stonehouse, the Company’s Chief Executive Officer, to serve as Interim Chief Financial Officer and Interim Principal Accounting Officer, effective as of the Effective Date.”
Affiliation history
-
Current
2026-06-11–present
-
Current
2025-04-09–present
-
Current
2025-04-09–present
-
Start not stated–2025-12-31
Company network
Leadership on record at Biocryst Pharmaceuticals Inc
- Charles Gayer CEO, Board Member
- Charlie Gayer CEO, Board Member
- Vincent J. Milano Chairman, Board Member
- Babar Ghias CFO, Chief Accounting Officer
- Thomas R. Staab II CFO
- A. Machelle Sanders Board Member
- Alan G. Levin Board Member
- Amy E. McKee Board Member
- Amy E. McKee, M.D. Board Member
- Amy McKee, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biocryst Pharmaceuticals Inc (BCRX) | Former President and Chief Executive Officer | $728,466 | $12,951,082 |
| 2024 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $705,536 | $8,317,286 |
| 2023 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $665,600 | $4,777,778 |
| 2022 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $640,000 | $6,982,994 |
| 2021 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $583,495 | $7,061,225 |
| 2020 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $566,500 | $6,034,941 |
| 2019 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $550,000 | $2,284,297 |
| 2018 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $550,000 | $4,167,643 |
| 2017 | Biocryst Pharmaceuticals Inc (BCRX) | President, Chief Executive Officer and Director | $532,823 | $3,921,189 |